Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Faculty Members have conducted research related to the Optimal Time-Point for 68Ga-Psma-11 Pet/Ct Imaging in Assessment of Prostate Cancer: Feasibility of Sterile Cold-Kit Tracer Preparation?
Reyhaneh Manafi-Farid
Reyhaneh Manafi-Farid

Assistant Professor of Nuclear Medicine

Department Nuclear Medicine

School of Medicine

Research Center for Nuclear Medicine

Tehran University of Medical Sciences

All Documents
1. Comparison of Diagnostic Performance of [68Ga]-Ga-Fapi-46 and [18F]-Fdg Pet/Ct Imaging for the Detection of Lesions and Disease Staging in Patients With Breast Cancer, Asia Oceania Journal of Nuclear Medicine and Biology (2025)
2. Correction To: The Role of [68Ga]Ga-Psma Pet/Ct in Primary Staging of Newly Diagnosed Prostate Cancer: Predictive Value of Pet-Derived Parameters for Risk Stratification Through Machine Learning (Clinical and Translational Imaging, (2024), 12, 6, (669-682), 10.1007/S40336-024-00666-9), Clinical and Translational Imaging (2025)
3. Value of Two-Phase [68Ga]Ga-Psma Pet/Ct Imaging in Comparison With Optimized Delayed Imaging in Detecting Locoregional Prostatic Metastases, Iranian Journal of Nuclear Medicine (2025)
4. A Convolutional Neural Network–Based System for Fully Automatic Segmentation of Whole-Body [68Ga]Ga-Psma Pet Images in Prostate Cancer, European Journal of Nuclear Medicine and Molecular Imaging (2024)
5. Diagnostic Value of [68Ga]Ga-Pentixafor Pet/Ct in Malignant Melanoma: A Pilot Study, Nuclear Medicine Communications (2024)
6. Prognostic Significance of Baseline Clinical and [68Ga]Ga-Psma Pet Derived Parameters on Biochemical Response, Overall Survival, and Psa Progression-Free Survival in Metastatic Castration-Resistant Prostate Cancer (Mcrpc) Patients Undergoing [177Lu]Lu-Psma Therapy, Nuklearmedizin - NuclearMedicine (2024)
7. The Role of [68Ga]Ga-Psma Pet/Ct in Primary Staging of Newly Diagnosed Prostate Cancer: Predictive Value of Pet-Derived Parameters for Risk Stratification Through Machine Learning, Clinical and Translational Imaging (2024)
8. 68Ga-Fapi, a Twin Tracer for 18F-Fdg in the Era of Evolving Pet Imaging, Radiology-Nuclear Medicine Diagnostic Imaging: A Correlative Approach (2023)
9. Diagnostic Value of [68Ga]Ga-Pentixafor Versus [18F]Fdg Pet/Cts in Non-Small Cell Lung Cancer: A Head-To-Head Comparative Study, Nuclear Medicine Communications (2023)
10. The Prognostic and Therapeutic Value and Clinical Implications of Fibroblast Activation Protein-Α As a Novel Biomarker in Colorectal Cancer, Cell Communication and Signaling (2023)
11. 68Ga-Fapi-46 Pet/Ct in a Metastatic Castration-Resistant Prostate Cancer Patient With Low Psma Expression, Clinical Nuclear Medicine (2022)
12. [18F]Fdg Pet/Ct in a Case of Recurrent Primary Cardiac Osteosarcoma, Iranian Journal of Nuclear Medicine (2022)
13. [18F]Fdg-Pet/Ct Radiomics and Artificial Intelligence in Lung Cancer: Technical Aspects and Potential Clinical Applications, Seminars in Nuclear Medicine (2022)
14. Diagnostic Value of Lacrimal Scintigraphy in the Evaluation of Lacrimal Drainage System Obstruction: A Systematic Review and Meta-Analysis, Nuclear Medicine Communications (2022)
15. Disseminated Thoracoabdominal Splenosis Mimicking Metastatic Disease: A Case of Colorectal Cancer, Iranian Journal of Nuclear Medicine (2022)
16. Factors Predicting the Early Biochemical Response to [177Lu]Lu-Psma Therapy in Patients With Metastatic Castration Resistant Prostate Cancer, Iranian Journal of Nuclear Medicine (2022)
17. Immunopet: Antibody-Based Pet Imaging in Solid Tumors, Frontiers in Medicine (2022)
18. Impact of Tsh Stimulation on 2-[18F]Fdg Pet/Ct Results in Patients With Papillary Thyroid Carcinoma Presented With Elevated Serum Thyroglobulin Level and Negative Diagnostic Iodine-131 Whole-Body Scan, Iranian Journal of Nuclear Medicine (2022)
19. Nuclear Imaging in Patients With Differentiated Thyroid Cancer and Negative Radioactive Iodine Scan, Iranian South Medical Journal (2022)
20. Predictive and Prognostic Potential of Pretreatment 68Ga-Psma Pet Tumor Heterogeneity Index in Patients With Metastatic Castration-Resistant Prostate Cancer Treated With 177Lu-Psma, Frontiers in Oncology (2022)
21. Prognostic Value of 2-[18F]Fdg Pet-Ct in Metastatic Melanoma Patients Receiving Immunotherapy, European Journal of Radiology (2022)
22. 2-[18F]Fdg Pet/Ct Radiomics in Lung Cancer: An Overview of the Technical Aspect and Its Emerging Role in Management of the Disease, Methods (2021)
23. Factors Predicting Biochemical Response and Survival Benefits Following Radioligand Therapy With [177Lu]Lu-Psma in Metastatic Castrate-Resistant Prostate Cancer: A Review, European Journal of Nuclear Medicine and Molecular Imaging (2021)
24. Molecular Imaging in Primary Staging of Prostate Cancer Patients: Current Aspects and Future Trends, Cancers (2021)
25. Additional Value of 2-[18 F]Fdg Pet/Ct Comparing to Mri in Treatment Approach of Anal Cancer Patients, Journal of Clinical Medicine (2020)
26. Multiphasic 68Ga-Psma Pet/Ct in the Detection of Early Recurrence in Prostate Cancer Patients With a Psa Level of Less Than 1 Ng/Ml: A Prospective Study of 135 Patients, Journal of Nuclear Medicine (2020)
27. Pet/Ct and Pet/Mri, Normal Variations, and Artifacts, Clinical Nuclear Medicine: Second Edition (2020)
28. Targeted Palliative Radionuclide Therapy for Metastatic Bone Pain, Journal of Clinical Medicine (2020)
29. A Rare Presentation of Colorectal Cancer With Unusual Progressive Intramuscular and Subcutaneous Metastatic Spread, Asia Oceania Journal of Nuclear Medicine and Biology (2019)
30. Diagnostic Efficiency Of68ga-Dotatate Pet/Ct As Compared To99mtc-Octreotide Spect/Ct and Conventional Morphologic Modalities in Neuroendocrine Tumors, Asia Oceania Journal of Nuclear Medicine and Biology (2019)
31. Molecular Imaging of Bone Metastases Using Tumor-Targeted Tracers, Quarterly Journal of Nuclear Medicine and Molecular Imaging (2019)